Inhibitory effect of tumor cell-derived lactic acid on human T cells

Blood

Volumn 109, Issue 9, 2007, Pages 3812-3819

  Fischer, Karin ^a   Hoffmann, Petra ^a   Voelkl, Simon ^a   Meidenbauer, Norbert ^a   Ammer, Julia ^a   Edinger, Matthias ^a   Gottfried, Eva ^a   Schwarz, Sabine ^a   Rothe, Gregor ^b   Hoves, Sabine ^a   Renner, Kathrin ^a   Timischl, Birgit ^a   Mackensen, Andreas ^a   Kunz Schughart, Leoni ^a   Andreesen, Reinhard ^a   Krause, Stefan W ^a   Kreutz, Marina ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Laboratory Center Bremen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER 1;

ARTICLE; CANCER CELL; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DRUG BLOOD LEVEL; DRUG INHIBITION; HUMAN; HUMAN CELL; IMMUNE FUNCTION TEST; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN METABOLISM; SPHEROID CELL; T LYMPHOCYTE ACTIVATION;

EID: 34247352844     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-07-035972     Document Type: Article

References (43)

1. Zippelius A, Batard P, Rubio-Godoy V, et al. Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. Cancer Res. 2004;64:2865-2873.
2. Warburg O. [On the facultative anaerobiosis of cancer cells and its use in chemotherapy]. Munch Med Wochenschr. 1961;103:2504-2506.
3. Ebert BL, Gleadle JM, O'Rourke JF, et al. Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. Biochem J. 1996;313(pt 3):809-814.
4. Elson DA, Ryan HE, Snow JW, Johnson R, Arbeit JM. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. Cancer Res. 2000;60:6189-6195.
5. Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr Opin Genet Dev. 2001;11:293-299.
6. Jiang BH, Agani F, Passaniti A, Semenza GL. VSRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 1997;57:5328-5335.
7. Talks KL, Turley H, Gatter KC, et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol. 2000;157:411-421.
8. Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem. 2002;277:23111-23115.
9. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891-899.
10. Walenta S, Wetterling M, Lehrke M, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60:916-921.
11. Walenta S, Salameh A, Lyng H, et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol. 1997;150:409-415.
12. Walenta S, Schroeder T, Mueller-Klieser W. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. Curr Med Chem. 2004;11:2195-2204.
13. Huijgen HJ, Sanders GT, Koster RW, Vreeken J, Bossuyt PM. The clinical value of lactate dehydrogenase in serum: a quantitative review. Eur J Clin Chem Clin Biochem. 1997;35:569-579.
14. Durig J, Fiedler W, de Wit M, Steffen M, Hossfeld DK. Lactic acidosis and hypoglycemia in a patient with high-grade non-Hodgkin's lymphoma and elevated circulating TNF-alpha. Ann Hematol. 1996;72:97-99.
15. Argiles JM, Lopez-Soriano FJ. The energy state of tumor-bearing rats. J Biol Chem. 1991;266:2978-2982.
16. Cham CM, Gajewski TF. Glucose availability regulates IFN-gamma production and p70S6 kinase activation in CD8+ effector T cells. J Immunol. 2005;174:4670-4677.
17. Frauwirth KA, Thompson CB. Regulation of T lymphocyte metabolism. J Immunol. 2004;172:4661-4665.
18. Poole RC, Halestrap AP. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol. 1993;264:C761-C782.
19. Halestrap AP, Price NT. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J. 1999;343(pt 2):281-299.
20. Merezhinskaya N, Ogunwuyi SA, Mullick FG, Fishbein WN. Presence and localization of three lactic acid transporters (MCT1, -2, and -4) in separated human granulocytes, lymphocytes, and monocytes. J Histochem Cytochem. 2004;52:1483-1493.
21. Mackensen A, Carcelain G, Viel S, et al. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Invest. 1994;93:1397-1402.
22. Meidenbauer N, Marienhagen J, Laumer M, et al. Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients. J Immunol. 2003;170:2161-2169.
23. Fischer K, Andreesen R, Mackensen A. An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity. J Immunol Methods. 2002;259:159-169.
24. Carlsson J, Yuhas JM. Liquid-overlay culture of cellular spheroids. Recent Results Cancer Res. 1984;95:1-23.
25. Hardenborg E, Zuberovic A, Ullsten S, et al. Novel polyamine coating providing non-covalent deactivation and reversed electroosmotic flow of fused-silica capillaries for capillary electrophoresis. J Chromatogr A. 2003;1003:217-221.
26. Soga T, Ueno Y, Naraoka H, et al. Simultaneous determination of anionic intermediates for Bacillus subtilis metabolic pathways by capillary electrophoresis electrospray ionization mass spectrometry. Anal Chem. 2002;74:2233-2239.
27. Lee KH, Wang E, Nielsen MB, et al. Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression. J Immunol. 1999;163:6292-6300.
28. Nielsen MB, Monsurro V, Migueles SA, et al. Status of activation of circulating vaccine-elicited CD8+ T cells. J Immunol. 2000;165:2287-2296.
29. Anichini A, Molla A, Mortarini R, et al. An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions. J Exp Med. 1999;190:651-667.
30. Nakagomi H, Petersson M, Magnusson I, et al. Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res. 1993;53:5610-5612.
31. Lee PP, Yee C, Savage PA, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med. 1999;5:677-685.
32. Seo N, Hayakawa S, Takigawa M, Tokura Y. Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity. Immunology. 2001;103:449-457.
33. Gottfried E, Kunz-Schughart LA, Ebner S, et al. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood. 2006;107:2013-2021.
34. Mihm S, Droge W. Regulation of cytotoxic T-lymphocyte activation by L-lactate and pyruvate. Cell Immunol. 1985;96:235-240.
35. Severin T, Muller B, Giese G, et al. pH-dependent LAK cell cytotoxicity. Tumour Biol. 1994;15:304-310.
36. Loeffler DA, Juneau PL, Masserant S. Influence of tumour physico-chemical conditions on interleukin-2-stimulated lymphocyte proliferation. Br J Cancer. 1992;66:619-622.
37. Lardner A. The effects of extracellular pH on immune function. J Leukoc Biol. 2001;69:522-530.
38. Heming TA, Tuazon DM, Dave SK, et al. Post-transcriptional effects of extracellular pH on tumour necrosis factor-alpha production in RAW 246.7 and J774 A.1 cells. Clin Sci (Lond). 2001;100:259-266.
39. Redegeld F, Filippini A, Sitkovsky M. Comparative studies of the cytotoxic T lymphocyte-mediated cytotoxicity and of extracellular ATP-induced cell lysis: different requirements in extracellular Mg2 and pH. J Immunol. 1991;147:3638-3645.
40. Sutherland RM. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science. 1988;240:177-184.
41. Tilton WM, Seaman C, Carriero D, Piomelli S. Regulation of glycolysis in the erythrocyte: role of the lactate/pyruvate and NAD/NADH ratios. J Lab Clin Med. 1991;118:146-152.
42. Murray CM, Hutchinson R, Bantick JR, et al. Monocarboxylate transporter MCT1 is a target for immunosuppression. Nat Chem Biol. 2005;1:371-376.
43. Sommer F, Bischof S, Rollinghoff M, Lohoff M. Demonstration of organic anion transport in T lymphocytes: L-lactate and fluo-3 are target molecules. J Immunol. 1994;153:3523-3532.